Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin

Crommelin, 2013, Towards more effective advanced drug delivery systems, Int. J. Pharm., 454, 496, 10.1016/j.ijpharm.2013.02.020 Kobayashi, 2014, Cancer drug delivery: considerations in the rational design of nanosized bioconjugates, Bioconjug. Chem., 25, 2093, 10.1021/bc500481x Lammers, 2012, Drug targeting to tumors: principles, pitfalls and (pre-)clinical progress, J. Control. Release, 161, 175, 10.1016/j.jconrel.2011.09.063 Yamashita, 2013, Pharmacokinetic considerations for targeted drug delivery, Adv. Drug. Deliv. Rev., 65, 139, 10.1016/j.addr.2012.11.006 Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Bae, 2011, Targeted drug delivery to tumors: myths, reality and possibility, J. Control. Release, 153, 198, 10.1016/j.jconrel.2011.06.001 Pirollo, 2008, Does a targeting ligand influence nanoparticle tumor localization or uptake?, Trends Biotechnol., 26, 552, 10.1016/j.tibtech.2008.06.007 Ruenraroengsak, 2010, Nanosystem drug targeting: facing up to complex realities, J. Control. Release, 141, 265, 10.1016/j.jconrel.2009.10.032 Wolinsky, 2012, Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers, J. Control. Release, 159, 14, 10.1016/j.jconrel.2011.11.031 Stevenson, 2012, Reservoir-based drug delivery systems utilizing microtechnology, Adv. Drug Deliv. Rev., 64, 1590, 10.1016/j.addr.2012.02.005 Hart, 2011, Chemotherapeutic wafers for high grade glioma, Cochrane Database Syst. Rev., 3, 72 Liu, 2010, Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films, Ann. Surg. Oncol., 17, 1203, 10.1245/s10434-009-0856-z Luo, 2012, Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation, Int. J. Pharm., 425, 19, 10.1016/j.ijpharm.2012.01.012 Benny, 2008, In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model, FASEB J., 22, 488, 10.1096/fj.07-8801com Zhao, 2013, Paclitaxel-loaded poly(glycolide-co-caprolactone)-b-d-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy, Int. J. Nanomed., 8, 1947 Elstad, 2009, OncoGel (ReGel/paclitaxel) – clinical applications for a novel paclitaxel delivery system, Adv. Drug Deliv. Rev., 61, 785, 10.1016/j.addr.2009.04.010 Chu, 2002, A clinical study of 22.5mg. La-2550: a new subcutaneous depot delivery system for leuprolide acetate for the treatment of prostate cancer, J. Urol., 168, 1199, 10.1016/S0022-5347(05)64625-3 Tang, 2009, Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein, Int. J. Pharm., 365, 34, 10.1016/j.ijpharm.2008.08.018 DuVall, 2009, Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer, Anticancer Drugs, 20, 89, 10.1097/CAD.0b013e3283222c12 Agarwal, 2013, Injectable implants for the sustained release of protein and peptide drugs, Drug Discov. Today, 18, 337, 10.1016/j.drudis.2013.01.013 Thakur, 2014, Solvent induced phase inversion-based in situ forming controlled release drug delivery implants, J. Control. Release, 176, 8, 10.1016/j.jconrel.2013.12.020 Deng, 1999, Optimization of preparative conditions for poly-dl-lactide-polyethylene glycol microspheres with entrapped Vibrio cholera antigens, J. Control. Release, 58, 123, 10.1016/S0168-3659(98)00147-3 Chen, 2010, Fibrous composites with anisotropic distribution of mechanical properties after layer-by-layer deposition of aligned electrospun fibers, Adv. Eng. Mater., 12, 529, 10.1002/adem.200980079 Luo, 2012, Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation, Eur. J. Pharm. Biopharm., 82, 545, 10.1016/j.ejpb.2012.08.012 Kang, 2011, In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer, Biomaterials, 32, 4556, 10.1016/j.biomaterials.2011.03.007 Hamada, 2011, In vivo imaging of the molecular distribution of the VEGF receptor during angiogenesis in a mouse model of ischemia, Blood, 118, 93, 10.1182/blood-2010-12-322842 Emerich, 2000, Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors, Pharm. Res., 17, 767, 10.1023/A:1007576405039 Trombone, 2007, Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells, Genet. Vaccines Ther., 5, 1, 10.1186/1479-0556-5-9 Luo, 2014, Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers, Int. J. Pharm., 475, 438, 10.1016/j.ijpharm.2014.09.006 Yang, 2011, Core-sheath structured fibers with pDNA polyplex loadings for the optimal release profile and transfection efficiency as potential tissue engineering scaffolds, Acta Biomater., 7, 2533, 10.1016/j.actbio.2011.02.031 Xie, 2010, Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-β-cyclodextrin inoculations, Int. J. Pharm., 391, 55, 10.1016/j.ijpharm.2010.02.016 Gabr, 1997, Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH, Cancer Res., 57, 4811 Opanasopit, 2005, Influence of serum and albumins from different species on stability of camptothecin-loaded micelles, J. Control. Release, 104, 313, 10.1016/j.jconrel.2005.02.014 Han, 2013, Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions, Int. J. Pharm., 455, 85, 10.1016/j.ijpharm.2013.07.056 Yuan, 1995, Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size, Cancer Res., 55, 3752 Gratton, 2008, The effect of particle design on cellular internalization pathways, Proc. Natl. Acad. Sci. U.S.A., 105, 11613, 10.1073/pnas.0801763105 Ogston, 2003, A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival, Breast, 12, 320, 10.1016/S0960-9776(03)00106-1 Anjum, 1998, Selective involvement of caspase-3 in ceramide induced apoptosis in AK-5 tumor cells, FEBS Lett., 439, 81, 10.1016/S0014-5793(98)01343-X Scholzen, 2000, The Ki-67 protein: from the known and the unknown, J. Cell. Physiol., 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9